Mutual of America Capital Management LLC grew its position in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) by 5.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,087 shares of the biopharmaceutical company’s stock after buying an additional 627 […]
